Pharming Group NV operates in the Pharmaceutical preparations sector. Pharming Group NV is a Netherlands-based biotechnology company. Pharming develops protein therapeutics for the treatment of diseases with significant medical needs, including genetic disorders, immune system related diseases, ageing diseases and nutritional products. The Company's technologies include platforms for the production of protein therapeutics and technology and processes for the purification and formulation of these products, as well as technologies in the field of (deoxyribonucleic acid) DNA repair via its subsidiary DNage BV. Pharming products under development are divided into three categories: biopharmaceuticals, biomaterials, and bio-nutritionals. Products in an advanced stage of development and closest to commercialization are Rhucin and human lactoferrin for use in food products. Pharming has several partnerships and collaborations with, inter alia, Esteve, Aslan Group and Swedish Orphan Biovitrum. In our complete report available for purchase the company is compared to: Summit Corporation Plc, 4SC Ag and Nextgen Group PLC.